Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
The DOI matches its Crossref record.
Abstract
Recent evidence indicates that an impairment of neuronal adaptive and reparative processes might be a key feature of the pathomechanism of Alzheimer's disease. Aberrations in the reparative neuronal response are likely to result from alterations of intracellular signal transduction cascades. As a consequence of abnormal intracellular signalling, the activation of those molecular events might be triggered in neurones which, in dividing cells, would lead to cellular transformation. In the present study, changes in the expression of the cyclin-dependent kinase inhibitor p16, a regulator of the orderly progression through the cell cycle, were investigated by immunocytochemical methods in the temporal cortex of patients with Alzheimer's disease. Both neurofibrillary tangles and neuritic components of plaques showed strong p16 immunoreactivity. These findings support the hypothesis that an aborted attempt of terminally differentiated neurones to re-enter the cell cycle might be a critical event in the pathology of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased levels of p53, a key mediator of cellular senescence and apoptosis, have been reported in different brain regions and in lymphocytes from AD patients [192,201,202,203], as well as in neurons of mouse models of AD [204].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [201]
Citations
Cites
Still being checked.
Cited by
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Self-citationTau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595
“Similarly, elevated expression of the cyclin‐dependent kinase inhibitor 2a, Cdkn2a, is one of the most robust markers of cellular senescence, and its protein product, p16, colocalizes with NFTs in human AD (Arendt et al., 1996).”
BackgroundSynaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
“As the ras-MAP-kinase pathway also mediates mitogenic effects eventually resulting in activation of the cell cycle (see below), a scenario can be envisaged where a disturbed synaptotrophic action of APP triggers an aberrant activation of intracellular signaling cascades that eventually induce cell cycle activation and…”
BackgroundCellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514
Metadata
- Authors
- Lars Rödel, T. A., Gärtner, U., & Holzer, M.
- Affiliations
- Leipzig University (DE)
- ORCID
- Holzer, Max
- Venue
- NeuroReport
- Published
- 1996-11
- Volume
- 7
- Issue
- 18
- Pages
- 3047-3050
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W2005849137
- Cited by
- 250
- References
- 0
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 10 · 2023: 10 · 2022: 5 · 2021: 8 · 2020: 5 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 15 · 2014: 6 · 2013: 6 · 2012: 6
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroreport (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- p16, cyclin-dependent kinase inhibitors, Alzheimer's disease, neurofibrillary tangles, neuritic plaques, neuronal cell cycle re-entry, signal transduction, temporal cortex, neural repair
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Carrier Proteins, Humans, Immunohistochemistry, Signal Transduction, Neurites, Neurofibrillary Tangles, tau Proteins, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease. https://app.cochat.ai/papers/10.1097/00001756-199611250-00050
- The paper
- Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996). Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease. NeuroReport. https://doi.org/10.1097/00001756-199611250-00050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.